1.40
price up icon1.45%   0.02
 
loading

Finanzdaten der Geron Corp-Aktie (GERN)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
23.82%
49.04
39.60 47.54 28.27 0.882
Operating Expenses
9.20%
61.49
56.31 67.59 56.49 70.22
Benefits Costs and Expenses
-
- 72.84 - -
Costs And Expenses
9.20%
61.49
56.31 72.05 56.49 70.22
Depreciation and Amortization
2.29%
0.128
0.131 0.142 0.031 0.262
Operating Income/Loss
25.44%
-12.45
-16.70 -20.05 -28.21 -69.33
Income/Loss From Continuing Operations Before Tax
347.22%
49.04
-19.84 -25.30 28.27 -67.38
Income/Loss From Continuing Operations After Tax
17.44%
-16.38
-19.84 -25.75 -26.45 -67.38
Net Income/Loss
17.44%
-16.38
-19.84 -25.35 -26.45 -67.38
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
0.04%
666.17
665.91 6.0996 662.16 653.90
Diluted Average Shares
0.04%
666.17
665.91 6.0996 662.16 653.90
Basic Earnings Per Share
33.33%
-0.02
-0.03 -0.04 -0.04 -0.10
Diluted Earnings Per Share
33.33%
-0.02
-0.03 -0.04 -0.04 -0.10
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$86.64
price up icon 1.40%
$27.54
price up icon 0.58%
$25.98
price up icon 9.16%
$112.46
price up icon 8.66%
$145.10
price up icon 1.80%
biotechnology ONC
$341.80
price up icon 7.24%
Kapitalisierung:     |  Volumen (24h):